Back to Search

PETER KWON, MD

MD

Surgery Physician

NPI: 1356459929Individual

Specialties, Licenses & Credentials

Specialist

Specialist

Code: 174400000X

216778(NY)
Surgery PhysicianPrimary

Surgery

Code: 208600000X

216778(NY)

Research & Publications (20)

Compatibility of imported fire ant whole body extract with cat, ragweed, Dermatophagoides pteronyssinus, and timothy grass allergens.
PMID 19205287·Ann Allergy Asthma Immunol·2009
7-preclinical
4-1BB functions as a survival factor in dendritic cells.
PMID 19299708·J Immunol·2009
7-preclinical
Coumarin-derived Cu(2+)-selective fluorescence sensor: synthesis, mechanisms, and applications in living cells.
PMID 19191706·J Am Chem Soc·2009
7-preclinical
In vitro and in vivo photodynamic therapy of otitis media in gerbils.
PMID 19572273·Laryngoscope·2009
7-preclinical
Chromofluorescent indicator for intracellular Zn2+/Hg2+ dynamic exchange.
PMID 18681453·Org Lett·2008
7-preclinical
[Detection of rifampin resistant mycobacterium tuberculosis complex using denaturing HPLC].
PMID 18458504·Korean J Lab Med·2008
8-other
Poor neonatal adaptation in term infant. Fluoxetine toxicity.
PMID 18411855·Pediatr Ann·2008
5-case
Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.
PMID 18411854·Pediatr Ann·2008
5-case
Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
PMID 18210954·J Wound Care·2008
3-trial
Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.
PMID 17550570·Int J Dermatol·2007
3-trial
4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation.
PMID 17389581·J Leukoc Biol·2007
7-preclinical
Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.
PMID 17376197·Immunology·2007
7-preclinical
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.
PMID 16488337·J Am Acad Dermatol·2006
3-trial
A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis.
PMID 17033169·Dermatology·2006
4-observational
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
PMID 16488338·J Am Acad Dermatol·2006
3-trial
An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis.
PMID 16397279·J Clin Pharmacol·2006
6-review
Maintenance of osseointegration utilizing insulin therapy in a diabetic rat model.
PMID 15857104·J Periodontol·2005
7-preclinical
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I.
PMID 16699904·J Cutan Med Surg·2005
4-observational
Immune thrombocytopenia associated with efalizumab therapy for psoriasis.
PMID 16287807·Ann Intern Med·2005
8-other
Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: case report and review.
PMID 15965552·Clin Pediatr (Phila)·2005
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
384 CRYSTAL RUN RD, SUITE 201
MIDDLETOWN, NY 10941

Location

Practice Location

384 CRYSTAL RUN RD, MIDDLETOWN, NY
(845) 692-8780

Quick Facts

NPI
1356459929
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile